Caricamento...
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
BACKGROUND: New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O(6)-methylguanine DNA methyltransferase (MGMT) methylation and protein expression have been related to colorectal cancer treatment failure and tumor progression...
Salvato in:
Pubblicato in: | BMC Cancer |
---|---|
Autori principali: | , , , , , |
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
BioMed Central
2014
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4227111/ https://ncbi.nlm.nih.gov/pubmed/25015560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-511 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|